Abstract
OBJECTIVE
In the last few years a number of studies have found that metformin has a thyrotropin (TSH)-lowering effect in patients with type 2 diabetes (DM2) and that this effect disappears after discontinuation of the drug. Initial studies were carried out in hypothyroid patients on levothyroxine (LT4) treatment. However, this effect was observed only when serum TSH levels were elevated. The aim of this study was to assess the effect of metformin treatment on serum TSH levels in euthyroid DM2 patients.
DESIGN
A retrospective study was conducted in seven primary health care centers in Spain. The study included 278 DM2 patients (110 females). Serum TSH level was tested before and one year after the onset of metformin treatment. We compared both TSH levels by paired t-tests. The sample was divided into four hierarchical clusters (C1 to C4), according to the Euclidean distance of the initial TSH level. No patient received LT4 treatment.
RESULTS
Pre-metformin serum TSH level (2.00±0.76 mU/L) was statistically significantly lower than post-metformin level (2.20±0.87 mU/L; P <0.001). Interestingly, this trend was observed only in clusters 1 and 2 (those with lower baseline TSH levels), whereas the trend was lost in clusters 3 and 4. The difference between pre- and post-metformin TSH levels follows a mathematical model. According to this model, the TSH threshold point level is 3.00 mU/L.
CONCLUSION
Metformin seems to induce a “buffer effect” on TSH secretion in euthyroid diabetic individuals. Hence, our study found an unreported TSH behavior after metformin treatment.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Wild S, Roglic G, Green A, Sicree R, King H, 2004 Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047–1053.
Canaris GJ, Manowitz NR, Mayor G, Ridgway EC, 2000 The Colorado thyroid disease prevalence study. Arch Intern Med 160: 526–534.
Perros P, McCrimmon RJ, Shaw G, Frier BM, 1995 Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med 12: 622–627.
Wu P, 2007 Thyroid disorders and diabetes. It is common for a person to be affected by both thyroid disease and diabetes. Diabetes Self Manag 24: 80–82, 85–87.
Chubb SA, Davis WA, Inman Z, Davis TM, 2005 Prevalence and progression of subclinical hypothyroidism in women with type 2 diabetes: the Fremantle Diabetes Study. Clin Endocrinol (Oxf) 62: 480–486.
Nathan DM, Buse JB, Davidson MB, et al, American Diabetes Association; European Association for the Study of Diabetes; 2009 Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 32: 193–203.
Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ, 1994 Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 43: 647–654.
Dunaif A, 2008 Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome-a reappraisal. Nat Clin Pract Endocrinol Metab 4: 272–283.
Vigersky RA, Filmore-Nassar A, Glass AR, 2006 Thyrotropin suppression by metformin. J Clin Endocrinol Metab 91: 225–227.
Isidro ML, Penín MA, Nemiña R, Cordido F, 2007 Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy. Endocrine 32: 79–82.
Cappelli C, Rotondi M, Pirola I, et al, 2009 TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients. Diabetes Care 32: 1589–1590.
Cappelli C, Rotondi M, Pirola I, et al, 2012 Thyreotropin levels in diabetic patients on metformin treatment. Eur J Endocrinol 167: 261–265.
Diez JJ, Iglesias P, 2013 Relationship between serum thyrotropin concentrations and metformin therapy in euthyroid patients with type 2 diabetes. Clin Endocrinol (Oxf) 78: 505–511.
Morteza Taghavi S, Rokni H, Fatemi S, 2011 Metformin decreases thyrotropin in overweight women with polycystic ovarian syndrome and hypothyroidism. Diab Vasc Dis Res 8: 47–48.
Rotondi M, Cappelli C, Magri F, et al, 2011 Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome. Clin Endocrinol (Oxf) 75: 378–381.
Alevizaki M, 2013 Metformin and the thyroid: some questions still remain. Clin Endocrinol (Oxf) 78: 503–504.
Santos-Palacios S, Brugos-Larumbe A, Guillén-Grima F, Galofré JC, 2013 A cross-sectional study of the association between circulating TSH level and lipid profile in a large Spanish population. Clin Endocrinol (Oxf) 79: 874–881.
Rezzónico J, Rezzónico M, Pusiol E, Pitoia F, Niepomniszcze H, 2011 Metformin treatment for small benign thyroid nodules in patients with insulin resistance. Metab Syndr Relat Disord 9: 69–75.
Oleandri SE, Maccario M, Rossetto R, et al, 1999 Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity. J Endocrinol Invest 22: 134–140.
Lupoli R, Di Minno A, Tortora A, Ambrosino P, Arianna Lupoli G, Di Minno MN, 2014 Effects of Treatment With Metformin on TSH Levels: A Meta-analysis of Literature Studies. J Clin Endocrinol Metab 99: E143–148.
Krysiak R, Okopien B, 2011 Thyrotropin-lowering effect of metformin in a patient with resistance to thyroid hormone. Clin Endocrinol (Oxf) 75: 404–406.
Bogachus LD, Turcotte LP, 2010 Genetic downregulation of AMPK-alpha isoforms uncovers the mechanism by which metformin decreases FA uptake and oxidation in skeletal muscle cells. Am J Physiol Cell Physiol 299: 1549–1561.
Duntas LH, Orgiazzi J, Brabant G, 2011 The interface between thyroid and diabetes mellitus. Clin Endocrinol (Oxf) 75: 1–9.
Fox CS, Pencina MJ, D’Agostino RB, et al, 2008 Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Arch Intern Med 168: 587–592.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Santos-Palacios, S., Brugos-Larumbe, A., Guillén-Grima, F. et al. Does metformin have a “buffer effect” on serum TSH levels in euthyroid diabetic patients?. Hormones 14, 280–285 (2015). https://doi.org/10.14310/horm.2002.1559
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.14310/horm.2002.1559